The Guardian - Pharmaceutical Industry

JUNE 19, 2023

UK’s largest stock-market-listed firm weighs up Hong Kong or Shanghai listing to shield it from geopolitical tensions Business live – latest updates AstraZeneca is considering spinning off its business in China and listing it in Hong Kong or Shanghai to shield the multinational drugmaker from geopolitical tensions.

41

41

PharmaShots

JUNE 14, 2023

The diagnostic and testing companies have been serving as a pivotal foundation stone of the healthcare sector With a global market value of $165.58B in 2021, the diagnostic and testing market size is anticipated to touch the threshold of $348.75 The company divides its business into Life Science and Clinical Diagnostic Segments.

Hospitals 56

Hospitals Documentation Drug Development 56

The Guardian - Pharmaceutical Industry

SEPTEMBER 9, 2023

Thanks to booming demand for its weight loss treatment Wegovy, the Danish business last week became Europe’s biggest company by stock market value, overtaking the previous holder of that title, French luxury group LVMH. The building looks like a sci-fi film set made by Lego, another stalwart of the Danish economy.

50

50

pharmaphorum

JUNE 1, 2022

GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new company on the London Stock Exchange set for 18 July. A listing on the New York Stock Exchange will follow shortly, according to the pharma group.

Vaccines 105

Vaccines 105

European Pharmaceutical Review

MAY 11, 2023

Delivering end-to-end expertise and solutions from research discovery to development, and diagnosis to cure, Revvity provides reagents, consumables, assays, instruments and software to customers in markets ranging from pharma and biotech , diagnostic labs, academia and government agencies. A livestream of the ceremony can be viewed here.

76

76

Digital Pharmacist

JANUARY 25, 2024

Now that we understand the importance of a Google Business Profile, let’s walk through the steps to set one up: Now that we understand the importance of a Google Business Profile, let’s walk through the steps to set one up: In the digital age, online visibility is crucial for businesses to thrive.

Customer Service 94

Customer Service Pharmacy Management Vaccines 94

pharmaphorum

JULY 18, 2022

GSK’s consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion). billion last year.

Vaccines 114

Vaccines 114

PharmaShots

JUNE 29, 2023

A portmanteau of nutrients and pharmaceuticals, nutraceuticals are colloquially known as medical foods With a market size of $413B in 2021, the nutraceutical market value is forecasted to cross the threshold of $650B by 2030 by marking a remarkable CAGR of 3.9 percent from 2021 to 2030. Revenue: $277.2M

Immunity 40

Immunity Immunization 40

PharmaShots

MAY 10, 2023

Bolstered by the inch-perfect result and cutting-edge technology, gradually medical devices have got profoundly embedded in our lives With a global market value of $562.6B The company has divided its business into four segments i.e., Imaging, Diagnostics, Varian, and Advanced Therapies.

Nursing Homes 40

Nursing Homes Hospitals Physician Offices Diabetes 40

The Guardian - Pharmaceutical Industry

DECEMBER 7, 2022

You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses Flotation fever is a dangerous condition, and the bout experienced in early 2021, we can now say, was severe. One could even call the business model clever. Now comes Moonpig.

41

41

pharmaphorum

JANUARY 17, 2022

The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%. GSK explained its decision to reject the proposals, “on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects”. billion (£50 billion).

116

116

pharmaphorum

JULY 23, 2021

GlaxoSmithKline has said that Brian McNamara – currently head of its three-year-old consumer health joint venture with Pfizer – will retain the top job at the business after it is hived off into a separate company next year. billion) and leading positions in the US and Chinese markets.

Vaccines 111

Vaccines 111

PharmaShots

FEBRUARY 21, 2023

With the growing influence of radiopharmaceutical companies in oncology, the companies hold a firm grasp on the market. With the expanding acceptance among HCPs, patients, and researchers, radiopharmaceutical companies are estimated to touch the $7.5B threshold by 2026.

Dosage 56

Dosage Labelling Immunity Immunization 56

European Pharmaceutical Review

JULY 11, 2023

WuXi XDC) on the Main Board of the Hong Kong Stock Exchange (HKEX). As some of the opportunities in the fast-growing global bioconjugate market are currently beyond the business scope of WuXi Bio, the proposed spin-off will facilitate the company to capture the market.

65

65

PharmaShots

MAY 23, 2023

Propelled by constant innovatory winds, the Cell and Gene therapy market is anticipated to grow by 20 percent year-over-year through 2025. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M With a total revenue of $52B, Merck & Co. Total Revenue: $3.6M

Diabetes 58

Diabetes Immunity Immunization Pharmaceutical Companies 58

Express Pharma

JUNE 28, 2023

The value of India’s retail pharmaceutical market is estimated to touch $59 billion by the fiscal year 2023, which presents a promising opportunity for retail pharmacies to bolster and strengthen their operations. However, a management system can help ensure the security and availability of all medicine stocks, resulting in cost savings.

Online Pharmacies 98

Online Pharmacies Customer Service Data Entry Packaging 98

Pharmaceutical Technology

APRIL 17, 2023

NKGen Biotech, a clinical-stage natural killer (NK) cell therapy firm, has signed a definitive agreement to combine its business operations with Graf Acquisition. Graf is also anticipated to be listed on the New York Stock Exchange, NYSE American and Nasdaq under the ticker symbol ‘NKGN’.

98

98

epicur

DECEMBER 5, 2022

Quick Facts: The veterinary compounding market is expected to increase from US$ 1.1 Quick Facts: The veterinary compounding market is expected to increase from US$ 1.1 However, retail stores and online pharmacies have stolen a lot of market share, especially during the pandemic. Bn in 2020 to over US$ 2.7

Compounding 52

Compounding Compounding Pharmacies Packaging Hospitals 52

Pharmaceutical Technology

NOVEMBER 8, 2022

According to the deal, the purchase price, contingent on adjustments, has to be paid by Fulgent Genetics as a combination of cash on hand and its shares of common stock. With the takeover, Fulgent Genetics intends to transform into a completely integrated precision medicine firm focusing on oncology from a genomic diagnostic business.

52

52

pharmaphorum

JULY 25, 2022

The all-stock transaction values Zymergen at an approximately $300 million, a fraction of the $1 billion it raised in venture funding with another $530 million from its initial public offering in April 2021. ” The post Ginkgo buys Zymergen, but may shed drug discovery business appeared first on.

52

52

Pharmaceutical Technology

OCTOBER 20, 2022

Ayala Pharmaceuticals has signed a definitive merger agreement with biotechnology company Advaxis, which discovers, develops and markets immunotherapies. The business combination would result in a merged company that will mainly focus on developing and marketing Ayala’s AL102 and Advaxis’ ADXS-504.

52

52

Pharmaceutical Business Review

MARCH 30, 2023

At present, the shares of Sensidose are listed on Spotlight Stock Market in Sweden. Sensidose is involved in the marketing of drugs in combination with an innovative device for individual dosing to treat patients with advanced Parkinson’s disease. The independent bid committee of Sensidose has recommended the cash offer.

52

52

pharmaphorum

NOVEMBER 27, 2022

Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication. Cutting down on safety stock. This means batch sizes can be tailored to daily demands rather than market forecasts. Reducing capacity issues.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7.

129

129

pharmaphorum

JANUARY 11, 2021

US wholesale giant AmerisourceBergen is to buy the majority of Walgreens Boots Alliance’s wholesaling business for around $6.5 AmerisourceBergen will pay $6.275 billion in cash and around 2 million shares of its common stock for Alliance Healthcare in a deal to support its global distribution business.

66

66

RX Note

OCTOBER 15, 2023

Introduction A community pharmacy preceptor once told me that tidying up the shelves at the pharmacy counter each morning before starting business not only gives a good impression to customers because the items are neatly arranged, but it also makes you feel good to start a day. This business strategy does not work long-term.

Community Pharmacies 40

Community Pharmacies Customer Service 40

PharmaShots

APRIL 25, 2023

In 2022, the global market size of RNAi drug delivery was valued at $69.2B. Founded Year: 1994 Total Employees: ~120 Headquarters: London, United Kingdom Market Cap: $189.2M Founded Year: 1994 Total Employees: ~120 Headquarters: London, United Kingdom Market Cap: $189.2M R&D Expenditure: $64.2M R&D Expenditure: $84.4M

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Diabetes Packaging Immunity 40

epicur

DECEMBER 19, 2022

This new guidance, Guidance for Industry #256 (GFI 256), affects both office stock in veterinary practices and individual animal-patient prescriptions. For example, Apomorphine 2.5mg/ml injection for use in dogs is on the list but no other strength can be compounded for office stock from a 503A compounding pharmacy.

Compounding 52

Compounding Compounding Pharmacies Documentation Dosage 52

pharmaphorum

NOVEMBER 13, 2020

Since Covid-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance the reduced ability for physical interactions. And for those pharma businesses that can get it right, digital adoption is certainly the way forward.

Online Pharmacies 108

Online Pharmacies Pharmaceutical Companies Pharmaceutical Companies 108

Pharmaceutical Technology

SEPTEMBER 22, 2022

Sesen Bio has signed a definitive merger agreement to combine its business with Carisma Therapeutics and create a clinical-stage biotechnology firm in an all-stock deal. . Carisma president and CEO Steven Kelly will lead the combined business. Topic sponsors are not involved in the creation of editorial content.

Immunity 52

Immunity Immunization 52

Pharmaceutical Technology

SEPTEMBER 6, 2022

Business optimism improved in August 2022 compared to July 2022, according to an ongoing poll by Verdict, despite businesses expressing concern over inflation, particularly in raw materials and energy costs. Business confidence improves in three of the UK’s regions. Indian firms witness stronger growth and softer cost pressures.

52

52

pharmaphorum

OCTOBER 1, 2021

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards the £5 billion ($6.7 The post Oxford Nanopore makes stellar debut on UK stock market appeared first on. billion) mark.

Documentation 52

Documentation Vaccines 52

pharmaphorum

JANUARY 6, 2023

With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors. The notion of making fewer mistakes with your existing business practices, rather than expanding your footprint, might seem overly conservative for a robust industry. Ensuring patient access.

Diabetes 105

Diabetes Pharmaceutical Companies Pharmaceutical Companies 105

Digital Pharmacist

NOVEMBER 23, 2022

Section 179 is a tax deduction for businesses. Section 179 is a tax code created to help businesses. By allowing businesses to deduct the full amount of the purchase price of equipment (up to certain limits). By allowing businesses to deduct the full amount of the purchase price of equipment (up to certain limits).

Pharmacy Automation 52

Pharmacy Automation Communication Pharmacy Management 52

pharmaphorum

FEBRUARY 28, 2022

billion in cash and providing another $1 billion in stock under the terms of the deal, which has been approved by the boards of both companies and is expected to close in the second half of this year. India’s Biocon has expanded its pipeline of biosimilars with a $3.3 Biocon is paying $2.3 billion.

Biosimilars 94

Biosimilars Customer Service 94

pharmaphorum

OCTOBER 28, 2020

Stocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK start-up Base Genomics. Exact Sciences said it has agreed to buy Thrive for a cash and stock deal worth up to $2.15 billion, positioning it as a leader in the cancer-screening market.

64

64

pharmaphorum

MARCH 1, 2021

billion windfall will be a boost to the UK pharma’s coffers during a busy time. AZ has a rich development pipeline and its busy completing its largest acquisition, the $39 billion purchase of rare diseases specialist Alexion. billion this year, which is significantly higher than market expectations.

Vaccines 64

Vaccines 64